CA2271560A1 - Forme galenique pharmaceutique concue pour etre administree dans le colon - Google Patents

Forme galenique pharmaceutique concue pour etre administree dans le colon

Info

Publication number
CA2271560A1
CA2271560A1 CA002271560A CA2271560A CA2271560A1 CA 2271560 A1 CA2271560 A1 CA 2271560A1 CA 002271560 A CA002271560 A CA 002271560A CA 2271560 A CA2271560 A CA 2271560A CA 2271560 A1 CA2271560 A1 CA 2271560A1
Authority
CA
Canada
Prior art keywords
dosage form
colon
coating material
polymer coating
inlet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002271560A
Other languages
English (en)
Other versions
CA2271560C (fr
Inventor
Gary Lee Manring
Gary Robert Kelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Clinic in Florida
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2271560A1 publication Critical patent/CA2271560A1/fr
Application granted granted Critical
Publication of CA2271560C publication Critical patent/CA2271560C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
CA002271560A 1996-11-15 1996-11-15 Forme galenique pharmaceutique concue pour etre administree dans le colon Expired - Fee Related CA2271560C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/018257 WO1998022095A1 (fr) 1996-11-15 1996-11-15 Forme galenique pharmaceutique conçue pour etre administree dans le colon

Publications (2)

Publication Number Publication Date
CA2271560A1 true CA2271560A1 (fr) 1998-05-28
CA2271560C CA2271560C (fr) 2003-09-23

Family

ID=22256126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002271560A Expired - Fee Related CA2271560C (fr) 1996-11-15 1996-11-15 Forme galenique pharmaceutique concue pour etre administree dans le colon

Country Status (4)

Country Link
KR (1) KR20000053327A (fr)
AU (1) AU739031B2 (fr)
CA (1) CA2271560C (fr)
WO (1) WO1998022095A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004020187D1 (de) * 2003-02-20 2009-05-07 Constant Res & Dev Ltd Prozess zur Herstellung einer Dexamethason enthaltenden Formulierung zur oralen Anwendung
KR101705204B1 (ko) * 2009-09-11 2017-02-09 롯데정밀화학 주식회사 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐
EP3854385A1 (fr) * 2020-01-27 2021-07-28 ROS Therapeutics ApS Forme posologique de méthotrexate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) * 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
JPH04368321A (ja) * 1991-06-17 1992-12-21 Kanegafuchi Chem Ind Co Ltd 大腸崩壊性コーティング剤および大腸崩壊性製剤
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
CA2156726C (fr) * 1993-02-26 2000-10-17 Paula Denise Davis Forme posologique de bisacodyl
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery

Also Published As

Publication number Publication date
WO1998022095A1 (fr) 1998-05-28
AU739031B2 (en) 2001-10-04
CA2271560C (fr) 2003-09-23
KR20000053327A (ko) 2000-08-25
AU7732496A (en) 1998-06-10

Similar Documents

Publication Publication Date Title
ATE251899T1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
CA2268175A1 (fr) Forme posologique pharmaceutique comportant plusieurs enrobages polymeres enteriques, destinee a agir dans le colon
CA2268868A1 (fr) Forme posologique de bisacodyl comprenant plusieurs enrobages polymeres enteriques pous assurer l'apport dans le colon
CA2305762C (fr) Systeme d'administration de medicaments a liberation totale prolongee destines au tractus gastro-intestinal
US6531152B1 (en) Immediate release gastrointestinal drug delivery system
US5891474A (en) Time-specific controlled release dosage formulations and method of preparing same
AU713722B2 (en) Gastrointestinal drug delivery system
CA2045472C (fr) Compositions pour l'administration de medicaments
CA2181502A1 (fr) Preparation pharmaceutique sous forme de capsule enrobee, liberee dans la partie inferieure du tube digestif
GB2310601A (en) Delayed release coated paracetamol particles
JPH07507564A (ja) コア及び厚さが一定でないコーティングを含有する物品
CA2271569A1 (fr) Forme galenique pharmaceutique comportant des revetements enteriques polymeres multiples pour administration dans le colon
CA2271560A1 (fr) Forme galenique pharmaceutique concue pour etre administree dans le colon
NO992349L (no) Farmas°ytisk doseform for avlevering i tykktarmen
BR9612800A (pt) Forma de dosagem farmacêutica para distribuição colÈnica.
NO992350L (no) Farmas°ytisk doseringsform med multiple enteriske polymerbelegg for avlevering i tykktarmen
BR9612801A (pt) Forma de dosagem farmacêutica com múltiplos revestimentos de polìmeros entéricos para o fornecimento colÈnico.
MXPA00003438A (en) Delayed total release gastrointestinal drug delivery system
CA2223014A1 (fr) Formulation a liberation controlee presentant un passage preforme

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed